MEET QPS AT THE WORLDSymposium™ 2024; February 4 - 9, SAN DIEGO, CALIFORNIA, USA

NPC1-/- Mouse Model

NPC1-/- Mouse Model

Niemann-Pick disease type C1 is an inherited lysosomal storage disorder that affects the viscera and the central nervous system. The disease is caused by defective intracellular processing and transport of low-density lipoprotein-derived cholesterol and causes accumulation of cholesterol and other lipids in lysosomes, subsequently altering cholesterol homeostasis.

Mice homozygous for the recessive NIH allele of the Niemann Pick type C1 gene (Npc1m1N) show a dual deficiency of sphingomyelinase and glucocerebrosidase activity (JAX# 003092). Animals are bred on a BALB/c OlaHsd background. For a detailed characterization of this mouse model see our publication Santiago-Mujica et al., 2019.

Tissue Cholesterol Levels

Total cholesterol levels were assessed in the liver and distinct brain regions of 6-week old NPC1-/- and wildtype animals. While total cholesterol levels were significantly increased in the liver of NPC1-/- animals compared to wild type littermates (Fig. 1A), total cholesterol levels in distinct brain regions were decreased in NPC1-/- mice compared to wild type littermates (Fig. 1B).

Figure 1-Total cholesterol summary

Figure 1. Absence of NPC1 in mice causes changes in the tissue cholesterol content. NPC1 deletion in mice leads to cholesterol accumulation in the liver (A) and decreased total cholesterol levels in distinct brain regions (B). 6-week old NPC1-/-, n = 6 per group, mice of both sexes were used. Statistical analyses using unpaired t-test revealed significant differences in cholesterol levels between knockout and wild type animals. Mean + SEM; *p<0.05; **p<0.01; ***p<0.001. 

Liver Enzymes in NPC1-/- Mice

The liver enzyme profile was assessed in the plasma of 7-week old NPC1-/- and wild type animals. Alkaline phosphatase (AP, Fig. 2A), aspartate aminotransferase (AST, Fig. 2B) and alanine aminotransferase (ALT, Fig. 2C) levels were significantly elevated in the plasma of NPC1-/- animals compared to wild type mice (Fig. 2).

Figure 2-Plasma Enzyme Levels

Figure 2. Absence of NPC1 in mice influences liver enzyme levels. Plasma of NPC1-/- and wild type littermates were evaluated for AP (A), AST (B) and ALT (C). 7-week old NPC1-/-, n = 8 per group, male mice only. Statistical analyses using unpaired t-test revealed significant differences in liver enzyme levels between NPC1-/- and wild type animals. Mean + SEM; ***p<0.001.
 
QPS Neuropharmacology offers custom-tailored study designs for this model and we are flexible to accommodate your specific interest. NPC1-/- mice show relevant features of Niemann-Pick disease already at young age. This allows for extraordinarily fast turn-around times.

We would be happy to test your compounds in the NPC1-/- mouse model! The most common readouts are:

You might be also interested in these related topics:

QPS Neuropharmacology is also ready to provide samples (brain tissue, CSF etc.) from these animals for analyses in your laboratory.

We are happy to receive your inquiry.

In Vitro Services

QPS Neuropharmacology provides research services with numerous standardized cell culture systems including transgenic and non-transgenic cell lines, glial cells, primary chicken and rat peripheral and central nervous system neurons of different developmental stages and organotypic brain slices. New models are developed and validated on request.
LEARN MORE

In Vivo Services

As a leading CRO for CNS drug development, QPS Neuropharmacology is the premier provider for services with transgenic animals. We have more than 20 years of experience in generating, characterizing, and maintaining transgenic disease models and applying them for drug testing projects.
LEARN MORE

Ex Vivo Services

QPS Neuropharmacology's expertise lies within the field of neurodegenerative diseases. We provide a state of the art research environment (AAALAC certified) for testing and evaluating new potential treatment approaches.
LEARN MORE

Biobank

QPS Neuropharmacology's well characterized and validated in vivo models are useful tools to push your CNS drug discovery research forward. We are happy to support your research activities with sample material from our biobank composed of various specimen derived from our in-house in vivo models.
LEARN MORE

animal models

QPS Neuropharmacology is highly experienced in generating, characterizing, and maintaining transgenic disease models and using them for drug testing projects for more than 20 years.
LEARN MORE

behavioral testing

QPS Neuropharmacology provides a wide range of behavioral tests for various indications. Most tests are evaluated using rater-independent digital animal tracking systems.
LEARN MORE

histology services

QPS Neuropharmacology offers a full set of histology services ranging from collection of tissue samples to delivering study reports that contain all experimental procedures and their outcome.
LEARN MORE

biomarkers

QPS Neuropharmacology Department of Translational Medicine offers a selection of molecular biological methods for the investigation of various diseases. The unit supports in vitro and in vivo studies performed at QPS Austria.
LEARN MORE